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a b s t r a c t
Normal pressure hydrocephalus (NPH) is a chronic disorder caused by interrupted CSF
absorption or ﬂow. Generally, shunt placement is ﬁrst option for NPH treatment. Due to
complications of ventriculo-peritoneal (VP) shunt placement, endoscopic third ventricu-
lostomy (ETV) can be considered as an alternative treatment option. Here we report the
efﬁcacy of ETV especially in old aged patients with normal pressure hydrocephalus.
Total 21 old aged patients with communicating hydrocephalus with opening pressure,
measured via lumbar puncture, less than 20 cm H2O underwent ETV. 15 patients had
primary/idiopathic NPH and 6 patients had secondary NPH. All patients were studied with
a MRI to observe the ﬂow void at aqueduct and the fourth ventricle outﬂow. And all of them
underwent ETV. In a group with peak velocity was higher than 5 cm/s, nine patients (75%)
were evaluated was 'favorable' and three of them (25%) was scored 'poor'. In another group
with peak velocity less than 5 cm/s, three of them were scored 'poor' and two of them were
scored 'stable'. None of them was evaluated as 'favorable'. We also evaluated the outcomes
according to etiology: 12 patients (80% of the patients with primary NPH) were evaluated
with 'favorable' after ETV treatment. Two patients (13.3%) were as 'stable'. And one patient
was as 'poor' evaluated. Five patients (83.3%) among patients with secondary NPH were as
'poor' evaluated and one of them was stable and no patient was as 'favorable' evaluated. 4
patients, which was as 'poor' evaluated in the group with the secondary NPH, underwent
additional VP shunt implantation. Overall, the outcomes of the group with the idiopathic
NPH after ETV treatment were more favorable than of the group with the secondary NPH.
Our study suggest that ETV can be effective for selected elderly patients with primary/
idiopathic NPH, when they satisfy criteria including positive aqueduct ﬂow void on T2
Sagittal MRI and the aqueductal peak velocity, which is greater than 5 cm/s on cine MRI.
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NPH is a chronic disorder, which is caused by impaired CSF
circulation. Hydrocephalus can be subdivided into communi-
cating and non-communicating 'obstructive' hydrocephalus.
The normal pressure hydrocephalus belongs to the commu-
nicating form in that the cause of CSF circulation is low
brain compliance. The exact pathogenesis of normal pressure
hydrocephalus has not been elucidated. NPH was ﬁrst
described by Hakim and Adams in 1965 [1,2]. It is characterized
by the clinical triad of gait disturbance, dementia, and
urinary incontinence [3,4]. The gait disturbance, which
represents with a combination of motor deﬁcits, failure of
postural righting reﬂexes, abnormal smooth pursuit, and
failed suppression of vestibuloocular reﬂexes [5,6] is usually
the ﬁrst symptom of normal pressure hydrocephalus to
appear, followed by dementia and last by urinary incontinence
[7]. Generally, VP shunt placement is considered as ﬁrst option
for NPH treatment. However, several complications, including
shunt infection, over drainage and malfunction including
obstruction [8–13] limit its application for treating NPH. Some
studies report an overall shunt failure rate as high as 59%, with
the majority of failures, occurring within the ﬁrst 6 months after
shunt placement [14]. Due to such complications, endoscopic
third ventriculostomy (ETV) has emerged as a surgical
intervention to treat hydrocephalus, as an alternative to shunt
implantation. ETV has become as one of ideal treatment
options generally for the most forms of obstructive hydroceph-
alus. In the last decade ETV has been proposed as an alternative
surgical intervention for treating iNPH. However, debate over VP
shunt implantation versus ETV for the treatment is still
ongoing. Although reported therapeutic efﬁcacy of ETV over
shunt implantation reported in some studies [15,16], Chan et al.
reported high complication rate associated with ETV interven-
tion [17]. However, therapeutic effect without implanting any
foreign material renders this method preferable to VP shunting
for a large ETV population. Several studies reporting the efﬁcacy
of the ETV predominantly include the pediatric patient group
[18–21] or combined pediatric and adult populations [22–27]. To
our knowledge, there is no study, suggesting selecting criteria
for ETV especially in old aged patients with normal pressure
hydrocephalus. In this present study, we report on the follow up
of ETV in a series of 21 patients (mean 70 years old) with normal
pressure hydrocephalus and suggest patients selecting criteria
for successful ETV intervention.
2. Materials and methods
In our present study, clinical data of 21 patients diagnosed
with normal pressure hydrocephalus, who chose the endo-
scopic third ventriculostomy from January 2013 to January
2014 were reviewed (Table 1a). Patients were fully informed
about their treatment options including surgical procedures,
anticipated results, complications and anticipated beneﬁts.
The patients fulﬁlled following diagnostic criteria (Table 1b): (1)
older than sixty years of age – age ranged from 60 to 82 years
old (mean 70 years old). (2) Communicating hydrocephalus
(ﬂow void was observed at aqueduct and 4th ventricle outﬂowon cine MRI). (3) Positive results of CSF tap test. (4) Opening
pressure less than 20 cm H2O. 15 patients among them had
iNPH and rest of them had sNPH. Causes for sNPH include
cerebral infarction and cerebral hemorrhagic contusion.
All 21 patients presented with gait ataxia. 48% of them have
urinary incontinency and 57% of them had memory deﬁciency.
63.6% of patients had more than two symptoms of NPH triad.
Preoperatively all patients were studied with MRI to observe the
ﬂow void at aqueduct and the fourth ventricle outﬂow. All
patients underwent ETV. The follow up period ranged from 1
month to 12 months (mean 6.4 months). Based on etiology, we
separated the patients into two groups. The ﬁrst group included
15 patients with iNPH, deﬁned as primary communicating
hydrocephalus. The second group included 6 patients with
sNPH. Evaluation of the efﬁcacy of ETV based on the postopera-
tive patients' status was performed comprehensively by physi-
cian. It was evaluated as 'preferable' when the comprehensive
postoperative status of patients indicates improvement. If there
were no big differences between pre- and postoperative but only
with a bit of improvement, we evaluated as 'stable'. When there
was no improvement or worsening symptoms, we evaluated it
as 'poor'. 'expire' was categorized as 'poor'.
3. OP procedure: endoscopic third
ventriculostomy
Endoscopic third ventriculostomy was performed using rigid
neuro-endoscope consisted of a 30-degree Hopkins pediatric
telescope (Karl Storz, Tuttlingen, Germany) with an outside
diameter of 2.7 mm, a sheath for the telescope with an outside
diameter of 3.8 mm, and a stylet. For perforating the third
ventricle ﬂoor, a monopolar-coagulating electrode was applied.
This operation was performed under general anesthesia. The
patient was positioned supine, and routine skin preparation and
draping were performed. A burr hole was placed at Kocher's
point. The right lateral ventricle was tapped using a ventricular
catheter through the burr hole, and peel-away catheter was
placedvia a tract. The tip ofa tapping catheter was directedto the
glabella and tragus of the right ear. A telescope with sheath was
advanced into the lateral ventricle through the peel-away
catheter. Foramen of Monro was identiﬁed, and the telescope
couldbeadvancedthroughtheforamenofMonro to visualizethe
ﬂoor of the third ventricle. The site for a third ventriculostomy
was located halfway along the midline between the infundibular
recess and the mammillary body. For penetration of the third
ventricular ﬂoor, the coagulating electrode or forceps was
advanced via a working channel in the sheath and electric
coagulation with the monopolar electrode was used. As the third
ventricular ﬂoor was perforated, a ﬂow of CSF was seen. The hole
could be enlarged with the insertion of the telescope or balloon
dilator ifneeded. The telescopeand its sheath were removedand
the cortical incision was packed with a piece of gel-foam and
sealed with ﬁbrin glue.
4. Results
Peak CSF ﬂow velocity at cerebral aqueduct on cine MR was
measured from 17 patients pre-operatively (Table 2). 4 Rest
Table 1a – Clinical features of preoperative patients.
No. Age Sex Gate disorder Urinary incontinency Memory deﬁciency
1 72 M y y y
2 73 F y y y
3 82 M y y y
4 66 M y n n
5 65 F y n n
6 67 F y y y
7 75 M y n n
8 61 F y y n
9 80 F y n n
10 76 M y n y
11 72 M y n n
12 72 M y n n
13 60 F y y n
14 60 F y y y
15 73 M y n y
16 73 M y n y
17 75 M y n n
18 63 M y n y
19 72 F y y y
20 72 M y y y
21 65 F y y y
Table 1b – CSF flow on MR imaging before the ETV and outcomes.
No. Pre Intervention Post Intervention
Opening pressure Peak velocity Flow void on stoma Immediate outcome Follow-up outcome VP shunt after ETV
1 9 14.7 y Favorable Favorable n
2 11 – y Favorable Poor (expired) n
3 11 – y Favorable Favorable n
4 14 7.54 y Favorable Poor y
5 6.5 22.3 y Favorable Favorable n
6 7 9.98 n Favorable Favorable n
7 16 11.6 y Favorable Favorable n
8 16 8.25 y Favorable Poor y
9 9 – y Favorable Stable n
10 9 2.18 y Favorable Poor y
11 9.5 7.73 y Favorable Favorable n
12 10 14.4 y Stable Favorable n
13 10 – y Favorable Favorable n
14 5 10.1 y Favorable Favorable n
15 10 7.55 y Favorable Favorable n
16 5 3.42 y Poor Poor n
17 5 9.85 n Favorable Poor n
18 3 9.02 y Favorable Favorable n
19 8 1.19 y Favorable Stable n
20 6 1.66 y Poor Poor y
21 13 2.92 y Favorable Stable n
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cine MR was not performed on them.
In a group with peak velocity of higher than 5 cm/s, nine
patients of them (75%) were evaluated as 'preferable' and three
of them (25%) were evaluated as 'poor'. In another group with
peak velocity of less than 5 cm/s, three of them were evaluated
as 'poor' and two of them as 'stable'. None of them was
evaluated as 'preferable' ( p < 0.008).
All 21 patients were evaluated based on post-operative
status. 15 patients of them were with iNPH and 6 of them had
sNPH. Among patients with iNPH, 12 patients (80%) wereevaluated with 'preferable'. Two patients (13.3%) were evalu-
ated as 'stable'. And one patient was as 'poor' evaluated. Five
patients (83.3%) among patients with sNPH were evaluated as
'poor' (Table 3). None of them in the group with sNPH was
evaluated as 'preferable'. 4 patients in this group of sNPH had
to undergo additional VP shunt (ProGAV) implantation. One of
these patients who underwent VP shunt insertion, had shunt
complication due to recurrent chronic subdural hemorrhage
caused by over-drainage. One patient, who underwent ETV,
was expired within the follow up period due to sepsis following
sore infection.
Table 3 – Primary NPH vs. secondary NPH.
 Primary NPH (15 patients)
* Good/Stable/Poor; 12(80%)/2(13.3%)/1(6.7%)
 Secondary NPH (6 patients)
* Good/Stable/Poor; 0(0%)/1(16.7%)/5(83.3%)
Table 2 – Peak velocity of cine MR (performed before the ETV).
Peak velocity Poor Stable Preferable Total
<5 cm/s 3 (60%) 2 (40%) 0 (0%) 5 (100%)
>5 cm/s 3 (25%) 0 (0%) 9 (75%) 12 (100%)
Total 6 (35.3%) 2 (11.8%) 9 (52.9%) 17 (100%)
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 2 9 – 3 4325. Discussion
Generally, shunt implantation is considered as primary
treatment option for hydrocephalus. However, since endo-
scopic technic was introduced, ETV has emerged as alternative
therapeutic option to shunt implantation due to lack of
complications associated with shunt infection, over drainage
and malfunction of the shunt [28–30]. Risk of shunt malfunc-
tion is relatively high: 25–40% in the ﬁrst year after shunt
placement, 4–5% per year thereafter, and 81% of shunted
patients require revision after 12 years, which demonstrates
that shunt failure is almost inevitable during a patient's life
[24,31]. So far, ETV has been employed mainly in patients with
'non-communicating' form of hydrocephalus [32]. In the last
decade, ETV become considered as one of options for
communicating hydrocephalus in context on retrieving CSF
ﬂow pathways.
According to Hakim et al. [33], brain parenchyma is
spongy viscoelastic, so that CSF pressure can be distributed
along the brain parenchyma. However, in NPH, compliance of
artery is decreased and vascular resistance are increased, so
that the increased pulsatile vascular expansion occurs [34].
As the CSF pressure exceeds the venous pressure, the
ventricles become enlarged and the systolic pulsations
continually damage the brain parenchyma [33,35]. This series
of process decreases elasticity of the brain parenchyma. In
case of iNPH, ETV may be able to cause a consequent increase
in the systolic outﬂow from the ventricle and decrease in
the intraventricular pulse pressure and width of the ventricle,
so that overall intracranial compliance can be increased [36].
The transmission of the pressure wave through ETV toward
the basal cistern may contribute to normalizing the CSF
dynamics [35].
Underlying diseases, which may cause sNPH, include
cerebral infarction, cerebral hemorrhage, and meningitis. In
our study ﬁve out of six patients had cerebral infarction. In
most cases of sNPH, arachnoid membrane is thick and
adhesive. Due to this defect of arachnoid membrane, CSF
ﬂow can be disturbed. An experimental study demonstrated
that impact of adhesions of the basal subarachnoid space is
worse than an intraventricular obstruction [36]. Present study
suggests that the transient increased site ﬂow through a small
perforation in the thinned ﬂoor of the third ventricle may notimprove the CSF dynamic in sNPH compared to the cases of
iNPH. In most cases of sNPH, VP shunt placement was
inevitable. The circulation of CSF is hampered in sNPH due
to defect arachnoid membrane, so that local perforation via
ETV may not enough to retrieve normal CSF circulation.
MR imaging is generally considered the best technique to
evaluate intracranial CSF dynamic, partly because of its ability
to image directly in the mid sagittal plane and partly due to the
various pulse sequences available. Cine-phase contrast MRI is
currently more used to evaluate pathophysiology of CSF
dynamic in patients with hydrocephalus. With the increasing
frequency of neuroendoscopic procedures including ETV, cine
MR imaging has been applied for evaluating the patency of
third ventriculostomy [37–40]. Several studies demonstrated
that the low intracranial compliance is associated with NPH
[41–44]. Lower aqueduct ﬂow velocity can account for low brain
compliance in communicating hydrocephalus. In our study,
nine out of twelve patients, in whom the peak velocity was
greater than 5 cm/s, experienced 'preferable' clinical outcome.
When the peak velocity is low (less than 5 cm/s) on preopera-
tive MR, ETV may not bring beneﬁts. In these patients, the CSF
dynamic may be not enough to squeeze the CSF through ETV
stoma site. To have positive effect and avoid treatment failure
through ETV, aqueduct peak velocity on cine MR should be
greater than 5 cm/s on cine MRI.
Our present study comprises several limitations including
the fact that the following period is relatively short (mean 6.4
months) so that complications, which can occur a year later,
were not counted so that a longer follow up is desirable. The
postoperative status of patients was comprehensively and
subjectively evaluated by physicians based on postoperative
clinical symptoms compared to the preoperative status of
patients so that bias may have occurred while evaluating the
result of the intervention. Small size of study group should be
also as limitation noted. Further studies with large population
and longer follow-up periods are mandatory to conﬁrm the
efﬁcacy of the treatment with ETV. Our results are not
sufﬁcient to determine its superiority over shunting for
NPH. However, when they are cautiously selected, ETV can
be effective for therapy of NPH.
6. Conclusion
Our present study emphasize that patient selection is the
key point for successful outcome in ETV. Our study suggests
that ETV is effective for selected elderly patients with
primary NPH. Criteria for ETV candidate in adult NPH patients
may include positive aqueduct ﬂow void on T2 Sagittal MRI
and the aqueductal peak velocity should be greater 5 cm/s
on cine MRI.
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